Minimally Invasive Right Hemicolectomy for Colorectal Disorders
(RICART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best method for performing a minimally invasive right hemicolectomy, a surgery to remove part of the colon for individuals with certain colorectal issues. Researchers compare two surgical techniques: intra-corporeal anastomosis (reconnecting the intestine inside the body) and extra-corporeal anastomosis (reconnecting it outside the body). The aim is to determine which method is more effective and results in fewer complications. The trial seeks adults scheduled for this specific surgery who are not undergoing additional colon surgeries simultaneously. As an unphased trial, it offers patients the chance to contribute to improving surgical techniques and outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this minimally invasive technique is safe for right hemicolectomy?
Research has shown that joining two parts of the intestine inside the body, known as intra-corporeal anastomosis, is a safe option for those undergoing minimally invasive surgery to remove part of the colon. Studies have found this method to be as safe as joining outside the body, with additional benefits.
One study found that patients who underwent the inside-the-body method experienced similar short-term results compared to those who had the outside-the-body method. Importantly, both methods had similar complication rates. Another study noted that the inside-the-body approach could even shorten hospital stays, aiding recovery.
Overall, these studies suggest that intra-corporeal anastomosis is well-tolerated and offers a safe alternative for patients considering minimally invasive colon surgery.12345Why are researchers excited about this trial?
Researchers are excited about intra-corporeal anastomosis in right hemicolectomy because it offers a minimally invasive approach that could enhance recovery for patients with colorectal disorders. Unlike traditional extra-corporeal methods, where the bowel is brought outside the body for reconnection, intra-corporeal anastomosis is performed internally. This technique may reduce surgical trauma, lower the risk of complications, and lead to quicker recovery times. By keeping the procedure within the body, there's potential for less pain and faster return to normal activities, which is why it's generating interest in the medical community.
What evidence suggests that intra-corporeal anastomosis is effective for colorectal disorders?
This trial will compare two techniques for minimally invasive right hemicolectomy: the internal connection technique (Intra-Corporeal Anastomosis) and the external connection technique (Extra-Corporeal). Research has shown that the internal connection technique can lead to faster recovery and fewer complications than the external connection technique. One study found that only 7.8% of patients using the internal method required additional surgeries, compared to 14.7% with the external method. Another analysis demonstrated that the internal technique significantly reduced overall complications and infection rates. It also lowered the risk of postoperative ileus, a condition where the bowel doesn't function properly after surgery. Overall, evidence suggests that the internal connection method could be a more effective option for a quicker and safer recovery.16789
Who Is on the Research Team?
James Ogilvie, MS
Principal Investigator
Spectrum Health Hospitals
Are You a Good Fit for This Trial?
This trial is for adults over 18 who need a right hemicolectomy, which is surgery to remove part of the colon, using minimally invasive methods. It's not for prisoners, those unable to consent, emergency cases, pregnant women or if additional colon resection like left colectomy is planned.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a right hemicolectomy via a minimally invasive approach with intra-corporeal or extra-corporeal anastomosis
Postoperative Monitoring
Participants are monitored for return of bowel function and other secondary outcomes such as surgical site infection and postoperative narcotic use
Follow-up
Participants are monitored for surgical site infection and perioperative morbidity
What Are the Treatments Tested in This Trial?
Interventions
- Intra-Corporeal Anastomosis
Intra-Corporeal Anastomosis is already approved in European Union, United States, China for the following indications:
- Right hemicolectomy
- Colorectal surgery
- Right hemicolectomy
- Colorectal surgery
- Right hemicolectomy
- Colorectal surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spectrum Health Hospitals
Lead Sponsor